Industrialisation is still vital to economic development but some countries are struggling to reap its benefits 
Samsung Implements Emergency 6-Day Work Week to Combat Slowing Growth 
The hidden racist history of hair loss 
Personalized cancer treatments based on testing drugs quickly leads to faster treatment, better outcomes 
Samsung's Exynos 2500 Rumored to Eclipse Snapdragon 8 Gen 4 in Power Efficiency With 3nm SoC 
Rivian Expands Layoffs With Additional 1% of Jobs Amid Growing EV Market Woes 
Finland is the happiest country in the world – but our research suggests the rankings are wealth and status-oriented 
FENTY x PUMA Launches New Creeper Phatty Earth Tone Collection 
Is attachment theory actually important for romantic relationships? 
Volkswagen Unveils New EV Platform in China to Cut Costs, Challenge BYD 
In France, abortion rights and hijab bans highlight a double standard on women’s rights 
Mentorship is key to improving social and economic outcomes for Black youth 
Eye infections might seem like a minor complaint – but in some cases they can cause blindness and even death 
Why Africa can be the beating heart of South Korea’s technology industry 
S. Korea's Beer Imports Dip Amid Tsingtao Urination Incident; Japanese Brands See Resurgence 
Honey is said to help with hay fever symptoms – here’s what the research says about this claim 
Coca-Cola Japan and Kirin Holdings will develop health drinks that contain the live bacteria, lactococcus lactis strain plasma (LC-Plasma), an ingredient patented by Kirin that is used in the company's health drinks.
Kirin claims that the live bacteria boosts immunity in healthy people.
Kirin is the first among companies that make foods and beverages they claim to boost immunity to have been approved by Japan's Consumer Affairs Agency in 2020 to advertise its products as such.
Coca-Cola Japan plans to put LC-Plasma into three of its brands, Georgia, Irohasu, and Minute Maid.
The Consumer Affairs Agency has also given the go-ahead for the drinks to be advertised as having the advantage.
The partnership demonstrates Coca-Cola Japan's intention to improve its position in the health beverage market. According to market research firm Inryo Soken, Coca-Cola has a 26 percent market share in soft drinks but has not advanced significantly in the market for health beverages.
On the other hand, Kirin is increasing sales of its LC-Plasma component and sees health products as its next area of growth. It anticipates that by 2027, sales of health drinks will have increased fivefold from their current level to 50 billion yen.
Taisho Pharmaceutical Holdings, as well as candy manufacturers including Morinaga & Co. and Kanro, have already purchased the component from Kirin.
Although supplying a rival with distinctive ingredients would negate Kirin's advantage, collaborating with Coca-Cola might let it expand its market.
